5 result(s) for "Urethra"
  1. 1. Genital Culture
    For recovery of organisms frequently associated with genital infections.
    Key Value
    PROCEDURE_ID 111168
    PROCEDURE_NAME CULTURE - GENITAL
    ORDER_DISPLAY_NAME Genital Culture
    PROCEDURE_MASTER_NUMBER LAB10270
    epic_synonyms VAGINA URETHRAL PENIS CERVICAL VAGINAL CERVIX PENILE URETHRA
    pdm 6201110
    cpt 87070
    clinical_info For recovery of organisms frequently associated with genital infections.
    methodology Microbiology Culture
    reference_values

    Routine genital flora

    performing_location Northwell Health Laboratories If culture is positive, additional charge(s)/CPT code(s) may apply for identification and/or antibiotic susceptibilities performed when appropriate.
    compendium_synonyms
    volume 4965
    results [{"base_name": null, "common_name": null, "external_name": null, "component_name": null}]
    name Genital Culture
    weight 925
    match_type epic synonym exact
    rank 4
  2. 2. Genital Culture-DR
    Key Value
    PROCEDURE_ID 189496
    PROCEDURE_NAME GENITAL CULTURE-DR
    ORDER_DISPLAY_NAME Genital Culture-DR
    PROCEDURE_MASTER_NUMBER LAB14380
    epic_synonyms VAGINA URETHRAL PENIS CERVICAL VAGINAL CERVIX PENILE URETHRA
    pdm 245157
    cpt
    clinical_info
    methodology
    reference_values
    performing_location
    compendium_synonyms
    volume
    results [{"base_name": "CULTSTATUS", "common_name": "CULTURE STATUS", "external_name": "Genital Culture Status", "component_name": "LC GENITAL CULT STATUS"}, {"base_name": "CGEN", "common_name": "GENITAL CULTURE", "external_name": "Genital Culture Result 2", "component_name": "LC GENITAL CULT2"}, {"base_name": "GENCXSUSC", "common_name": "GENITAL CULTURE SUSCEPTIBILITY", "external_name": "Genital Culture Susceptibility", "component_name": "LC GENITAL SUSCEPT"}, {"base_name": "CGEN", "common_name": "GENITAL CULTURE", "external_name": "Genital Culture Result 4", "component_name": "LC GENITAL CULT4"}, {"base_name": "CGEN", "common_name": "GENITAL CULTURE", "external_name": "Genital Culture Result 3", "component_name": "LC GENITAL CULT3"}, {"base_name": "CGEN", "common_name": "GENITAL CULTURE", "external_name": "Genital Culture Result 1", "component_name": "LC GENITAL CULT1"}]
    name Genital Culture-DR
    weight 925
    match_type epic synonym exact
    rank 4
  3. 3. Gram Stain
    The Gram stain is a rapid, preliminary test to assess the quality of specimens, identify bacterial infections, and to guide initial antibacterial therapy. NOTES: • Specimen source is required on request form for processing. • Gram Stain is automatically included when a culture is ordered for the following sources: body fluid, CSF, tissue, bronc...
    Key Value
    PROCEDURE_ID 1148
    PROCEDURE_NAME GRAM STAIN
    ORDER_DISPLAY_NAME Gram Stain
    PROCEDURE_MASTER_NUMBER LAB250
    epic_synonyms GS
    pdm 6201312
    cpt 87205
    clinical_info The Gram stain is a rapid, preliminary test to assess the quality of specimens, identify bacterial infections, and to guide initial antibacterial therapy. NOTES: • Specimen source is required on request form for processing. • Gram Stain is automatically included when a culture is ordered for the following sources: body fluid, CSF, tissue, bronchial alveolar lavage, sputum and surgical swabs received in Eswabs. • Gram stain is not reliable for diagnosis of cervical, rectal, pharyngeal, or asymptomatic urethral gonococcal infection. In these cases, culture or molecular detection should be ordered.
    methodology Microscopic examination
    reference_values

    No organisms observed

    performing_location Northwell Health Laboratories
    compendium_synonyms
    volume 2956
    results [{"base_name": null, "common_name": null, "external_name": null, "component_name": null}]
    name Gram Stain
    weight 600
    match_type clinical info substring
    rank 15
  4. 4. Prostate Health Index
    Aiding in distinguishing prostate cancer from benign prostate conditions in men with prostate-specific antigen (PSA) concentrations in the 4 to 10 ng/mL range and digital rectal examination (DRE) findings that are not suspicious for cancer   Prostatic biopsy is required for diagnosis of cancer.
    Key Value
    PROCEDURE_ID 115105
    PROCEDURE_NAME PROSTATE HEALTH INDEX (PHI) SERUM
    ORDER_DISPLAY_NAME Prostate Health Index
    PROCEDURE_MASTER_NUMBER LAB11381
    epic_synonyms PHI11
    pdm 1759181
    cpt 84153
    clinical_info Aiding in distinguishing prostate cancer from benign prostate conditions in men with prostate-specific antigen (PSA) concentrations in the 4 to 10 ng/mL range and digital rectal examination (DRE) findings that are not suspicious for cancer   Prostatic biopsy is required for diagnosis of cancer.
    methodology Immunoenzymatic Assay
    reference_values

    Females: Not applicable
     
    PROSTATE-SPECIFIC ANTIGEN (PSA) Males:

    Age Reference range
    <40 years <=2.0 ng/mL
    40-49 years <=2.5 ng/mL
    50-59 years <=3.5 ng/mL
    60-69 years <=4.5 ng/mL
    70-79 years <=6.5 ng/mL
    ?80 years <=7.2 ng/mL

     
    PERCENT FREE PSA
    Males:
    When PSA is in the range of 4-10 ng/mL

    % Free PSA Probability of cancer
    <=10% 56%
    11-15% 28%
    16-20% 20%
    21-25% 16%
    >25% 8%

     
    PROSTATE HEALTH INDEX (phi)
    Males:
    When PSA is in the range of 4-10 ng/mL

    phi range Probability of cancer 95% Confidence interval
    0-26.9 9.8% 5.2-15.4%
    27.0-35.9 16.8% 11.3-22.2%
    36.0-54.9 33.3% 26.8-39.9%
    >=55.0 50.1% 39.8-61.0%

    Calculation of prostate health index (phi) as a part of a reflex test when PSA concentrations are between 4 and 10 ng/mL
    Prostate-specific antigen (PSA) is a glycoprotein produced by the prostate gland, the lining of the urethra, and the bulbourethral gland. Normally, very little PSA is secreted in the blood. In conditions of increased glandular size and tissue damage, PSA is released into circulation. Measurement of serum PSA is useful for determining the extent of prostate cancer and assessing the response to prostate cancer treatment. PSA is also used as a screening tool for prostate cancer detection, although its use in screening has become controversial in recent years. While an elevated serum PSA is associated with prostate cancer, a number of benign conditions, such as benign prostatic hyperplasia (BPH) and prostatitis might lead to elevated serum PSA concentrations. As a consequence PSA lacks specificity for prostate cancer detection.
     
    Several PSA isoforms have been identified that can further increase the specificity of PSA for prostate cancer. In particular, the [-2] form of proPSA (p2PSA) shows improved performance over either total or free PSA for prostate cancer detection on biopsy. The prostate health index (phi) is a formula that combines all 3 PSA forms (total PSA, free PSA, and p2PSA) into a single score. phi is calculated using the following formula: (p2PSA/free PSA) x square root of PSA.
     
    In a multicenter study that compared the performance of PSA, free PSA, p2PSA, and phi in men undergoing prostate biopsy due to a serum PSA concentration between 4 and 10 ng/mL, phi was the best predictor of any prostate cancer, high-grade cancer, and clinically significant cancer. At 95% clinical sensitivity, the clinical specificity of phi was 16.0%, compared to 8.4% for free PSA and 6.5% for PSA.

    performing_location Mayo Clinic Laboratories in Rochester
    compendium_synonyms
    volume 2
    results [{"base_name": "PSA", "common_name": "PSA", "external_name": "Prostate Specific Antigen", "component_name": "PROSTATE SPECIFIC ANTIGEN, S"}]
    name Prostate Health Index
    weight 400
    match_type reference values substring
    rank 17
  5. 5. Trichomonas vaginalis Molecular Detection
    For molecular detection of Trichomonas vaginalis from urogenital sources.
    Key Value
    PROCEDURE_ID 115289
    PROCEDURE_NAME TRICHOMONAS VAGINALIS AMPLIFICATION
    ORDER_DISPLAY_NAME Trichomonas vaginalis Molecular Detection
    PROCEDURE_MASTER_NUMBER LAB11479
    epic_synonyms TV TRICHAMP
    pdm 6350820
    cpt 87661
    clinical_info For molecular detection of Trichomonas vaginalis from urogenital sources.
    methodology Transcription Mediated Amplification (TMA)
    reference_values

    T. vaginalis rRNA: Not detected

    performing_location Northwell Health Laboratories For Specimen Type: Urethral please order a MISC test
    compendium_synonyms
    volume 51241
    results [{"base_name": "SRCEAMP", "common_name": "SOURCE AMPLIFICATION", "external_name": "Source Amplification", "component_name": "SOURCE AMPLIFICATION"}, {"base_name": "TRICHOMONAS", "common_name": "TRICHOMONAS VAGINALIS AMP INTERP", "external_name": "Trichomonas vaginalis Amp Interpretation", "component_name": "TRICHOMONAS VAGINALIS AMP INTERP"}, {"base_name": "TRICHOMONAS", "common_name": "TRICHOMONAS VAGINALIS AMP RESULT", "external_name": "Trichomonas vaginalis Amp Result", "component_name": "TRICHOMONAS VAGINALIS AMP RESULT"}]
    name Trichomonas vaginalis Molecular Detection
    weight 300
    match_type performing location substring
    rank 18